| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |